Health care dragged on Wall Street in a jittery day of trading. Drugmakers were the biggest decliners after President Trump reasserted his promise to lower drug prices, though failed to detail his plans to do so. Michaels (MIK) rose after topping analysts' estimates in its fourth quarter and guiding for a better-than-expected full year. The arts and crafts retailer anticipated 2017 earnings of at least $2.05 a share, higher than $2.02 consensus. Pandora (P) fell after Liberty Media's CEO said an acquisition was unlikely as the music-streaming service was currently overvalued. Hopes were high Liberty would make an offer. Snap (SNAP) plummeted in a continued downswing following the highs of last week. The disappearing message app had rocketed higher in its market debut on Thursday, before concerns rose that its shares were overvalued.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.